7
Participants
Start Date
June 30, 2011
Primary Completion Date
June 30, 2012
Study Completion Date
June 30, 2012
Unintentional exposure in utero
This study will examine post-natal neurologic and cognitive development of infants who may have been exposed to tanezumab or comparator in-utero during the tanezumab clinical program (whether the exposure is through maternal or paternal participation in a tanezumab clinical study).
Pfizer Investigational Site, Duncansville
Pfizer Investigational Site, Cutler Bay
Pfizer Investigational Site, Houston
Pfizer Investigational Site, Salt Lake City
Pfizer Investigational Site, Tempe
Pfizer Investigational Site, Tempe
Pfizer Investigational Site, Wildomar
Pfizer Investigational Site, Memphis
Lead Sponsor
Pfizer
INDUSTRY